Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.395EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.120.2.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.416.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.532EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.408EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.550EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.261EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.238EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.631EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.627EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.519EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.514EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used